Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis
Open Access
- 1 February 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 127 (2) , 270-273
- https://doi.org/10.1046/j.1365-2249.2002.01727.x
Abstract
Summary: Atopic dermatitis (AD) is a chronic and relapsing inflammatory skin disease characterized by the predominant infiltration of T cells, eosinophils and macrophages in lesional skin. Recently, macrophage-derived chemokine (MDC)/CCL22, a CC chemokine, was identified as a selective chemoattractant for CC chemokine receptor 4 (CCR4)-expressing cells, in addition to thymus and activation-regulated chemokine (TARC). We have previously reported that serum TARC levels correlate with the severity of AD. In this report, we investigated the participation of MDC in AD. First, we measured serum MDC levels in 45 patients with AD, 25 patients with psoriasis vulgaris and 25 healthy controls. Serum MDC levels in AD patients were significantly higher than those in healthy controls and psoriasis patients. Furthermore, the increases in serum MDC levels in AD patients were greater in the severely affected group than in the moderate or mild groups. We compared serum MDC levels in 11 AD patients, before and after treatment, and observed a significant decrease after treatment. Moreover, the serum MDC levels significantly correlated with the Scoring AD (SCORAD) index, serum soluble (s) E-selectin levels, serum soluble interleukin-2 receptor (sIL-2R) levels, serum TARC levels and eosinophil numbers in peripheral blood. Our study strongly suggests that serum MDC levels have a notable correlation with disease activity and that MDC, as well as the CC chemokine TARC, may be involved in the pathogenesis of AD.Keywords
This publication has 24 references indexed in Scilit:
- Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activityJournal of Allergy and Clinical Immunology, 2001
- ChemokinesImmunity, 2000
- Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3– and CC chemokine receptor 4–independent mannerJournal of Allergy and Clinical Immunology, 1999
- Human Macrophage–derived Chemokine (MDC), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer CellsThe Journal of Experimental Medicine, 1997
- Soluble E-selectin as a marker of disease activity in atopic dermatitis☆, ☆☆, ★, ★★Journal of Allergy and Clinical Immunology, 1997
- Clinical Validation and Guidelines for the SCORAD Index: Consensus Report of the European Task Force on Atopic DermatitisDermatology, 1997
- Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.Journal of Clinical Investigation, 1994
- Severity Scoring of Atopic Dermatitis: The SCORAD IndexDermatology, 1993
- Responsiveness to Interleukin 4 and Interleukin 2 of Peripheral Blood Mononuclear Cells in Atopic DermatitisJournal of Investigative Dermatology, 1991
- Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasisBritish Journal of Dermatology, 1988